Guy E. Padbury
Impact in
- Virology top 10%
- HIV Research and Treatment
- Toxicology top 10%
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Antibiotics Pharmacokinetics and Efficacy 1
- Virology 3
- HIV Research and Treatment 3
- Co-authors
- Stephen G. Sligar (2 shared papers)Barry S. Lutzke (2 shared papers)Geri A. Sawada (2 shared papers)Thomas J. Raub (4 shared papers)Mark D. Prairie (1 shared paper)Thomas F. DeKoning (1 shared paper)Robert C. Kelly (1 shared paper)Tanya L. Wallace (1 shared paper)
- Journals
- Drug Metabolism and Disposition (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Chemical Research in Toxicology (1 paper)Biochemistry (1 paper)
- Partner nations
- United StatesNetherlandsNew Zealand
In The Last Decade
Guy E. Padbury
16 papers receiving 371 citations
Peers
Comparison fields: 5 of 73
- Virology 43
- Toxicology 22
- Pharmacology 40
- Organic Chemistry 114
- Oncology 99
Countries citing papers authored by Guy E. Padbury
This map shows the geographic impact of Guy E. Padbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy E. Padbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy E. Padbury more than expected).
Fields of papers citing papers by Guy E. Padbury
This network shows the impact of papers produced by Guy E. Padbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy E. Padbury. The network helps show where Guy E. Padbury may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy E. Padbury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue. | 1992 | 89 |
| 2 | 1996 | 84 | |
| 3 | 1997 | 61 | |
| 4 | 1999 | 60 | |
| 5 | 1988 | 33 | |
| 6 | 1985 | 23 | |
| 7 | 2007 | 17 | |
| 8 | 1999 | 10 | |
| 9 | 1996 | 8 | |
| 10 | 1998 | 5 | |
| 11 | 1994 | 4 | |
| 12 | 2011 | 4 | |
| 13 | 1996 | 3 | |
| 14 | 1997 | 3 | |
| 15 | 1997 | 3 | |
| 16 | 2006 | 1 |
About Guy E. Padbury
Guy E. Padbury is a scholar working on Pharmacology, Virology, Infectious Diseases, Oncology and Organic Chemistry, having authored 16 papers that have together received 408 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers), HIV Research and Treatment (3 papers), Cancer therapeutics and mechanisms (3 papers), Statistical Methods in Clinical Trials (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Chemical Reactions and Isotopes (1 paper). The work is most often cited by research in Virology (43 citations), Toxicology (22 citations), Pharmacology (40 citations), Organic Chemistry (114 citations) and Oncology (99 citations). Guy E. Padbury has collaborated with scholars based in United States, Netherlands and New Zealand. Frequent co-authors include Stephen G. Sligar, Barry S. Lutzke, Geri A. Sawada, Thomas J. Raub, Mark D. Prairie, Thomas F. DeKoning, Robert C. Kelly, Tanya L. Wallace, J. Patrick McGovren and Norman F.H. Ho. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmaceutical and Biomedical Analysis, Journal of Pharmacology and Experimental Therapeutics, Chemical Research in Toxicology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.